Marijuana Rescheduling Process Normally Steered by the DEA had been taken over by the U.S. Justice Department. The decision would not be signed by DEA ANNE MILGRAM but by Attorney General Merrick Garland.
Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in animal health since 1985
Clinical trials are expected to run for approximately ten months from May 24, 2024.
Read MoreVerification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024
Engaged Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
Management to Host Business Update Conference Call on Wednesday, May 22 at 4:30 p.m. Eastern Time
Read More
